[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100478488":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":38,"responsibleParty":72,"collaborators":10,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":10,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Mỹ Đức Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Recurrent pregnancy loss",null,"Women with history of recurrent pregnancy loss",[13],"Other: Vaginal swab and endometrial biopsy",{"label":15,"type":10,"description":16,"interventionNames":17},"Control","Normal fertile women",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Vaginal swab and endometrial biopsy","A vaginal swab (DNA\u002FRNA shield collection tube with swab - Zymo Research, CatNo R1107) and endometrial biopsy (Endobrush® - Lab CCD, Paris, France) will be obtained during 18th - 22nd day of the menstrual cycle.",[15,9],[24],{"name":25,"affiliation":26,"role":27},"Lan N Vuong, MD, PhD","University of Medicine and Pharmacy at Ho Chi Minh City","STUDY_CHAIR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Nam T Nguyen, MD","CONTACT","+84354120209","bsnam.nt@myduchospital.vn",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},"Tuong M Ho, MD, MCE","(+84) 903 633 377","bstuong.hm@myduchospital.vn",[39,58],{"facility":40,"status":41,"city":42,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"My Duc Hospital","RECRUITING","Ho Chi Minh City","70000","Vietnam","VN",{"type":47,"coordinates":48},"Point",[49,50],106.62965,10.82302,{"lat":50,"lon":49},[53,57],{"name":54,"role":31,"phone":55,"phoneExt":10,"email":56},"Vu NA Ho, MD","+84935843336","bsvu.hna@myduchospital.vn",{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"facility":59,"status":41,"city":42,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"My Duc Phu Nhuan Hospital",{"type":47,"coordinates":61},[49,50],{"lat":50,"lon":49},[64,68],{"name":65,"role":31,"phone":66,"phoneExt":10,"email":67},"Ho L Le, MD","+84356177147","bsho.ll@myduchospital.vn",{"name":69,"role":31,"phone":70,"phoneExt":10,"email":71},"Tien K Le, MD","+84962803875","bstien.lk@myduchospital.vn",{"type":73,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100478488","uterine-microbiome-in-recurrent-pregnancy-loss-100478488",false,"NCT05510622","Uterine Microbiome in Recurrent Pregnancy Loss","Reproductive Tract Microbiome in Women With Recurrent Pregnancy Loss","1. Recurrent pregnancy loss patients\n\n   Inclusion Criteria:\n   * 18-38 years old\n   * Having a regular menstrual cycle, from 25 to 35 days\n   * Having ≥ 2 recurrent pregnancy loss and\n   * Couples with normal karyotype results\n   * Having no condition causing pregnancy loss such as antiphospholipid syndrome, abnormal thyroid function.\n   * Agree to participate in the study\n\n   Exclusion Criteria:\n   * Irregular menstrual cycle\n   * Having uterine abnormalities (e.g., adenomyosis, intrauterine adhesions, unicornuate\u002F bicornuate\u002F arcuate uterus; unremoved hydrosalpinx, endometrial polyp, submucosal fibroid)\n   * Using intrauterine device within the last 3 months\n   * Using antibiotic\u002Fvaginal pessary\u002Fcontraceptive pills within 2 weeks\n   * Having sexual intercourse within 48 hours\n2. Healthy control patients\n\nInclusion Criteria:\n\n* 18-38 years old\n* Having a regular menstrual cycle, from 25 to 35 days\n* No history of pregnancy loss\n* Having 1 or more live birth, with the youngest child ≥ 6 months old\n* Agree to participate in the study\n\nExclusion Criteria:\n\n* Irregular menstrual cycle\n* Having uterine abnormalities (e.g., adenomyosis, intrauterine adhesions, unicornuate\u002F bicornuate\u002F arcuate uterus; unremoved hydrosalpinx, endometrial polyp, submucosal fibroid)\n* Using intrauterine device within the last 3 months\n* Using antibiotic\u002Fvaginal pessary\u002Fcontraceptive pills within 2 weeks\n* Having sexual intercourse within 48 hours",true,"FEMALE","18 Years","38 Years",{"count":86,"type":87},100,"ESTIMATED","OBSERVATIONAL","The female genital tract microbiome may reflect female reproductive health and may be related to pregnancy outcomes. Disturbances in this microbiome may be associated with adverse reproductive outcomes. The investigators hypothesize that the endometrial and vaginal microbiome composition in women with a history of recurrent pregnancy loss are different, compared with those in normal fertile women.",[91,92],"Recurrent Pregnancy Loss, Not Pregnant","Vaginal Microbiome",[94,95],"Microbiome","Recurrent Pregnancy Loss","2025-09-22",{"date":98,"type":99},"2025-09-25","ACTUAL",{"date":101,"type":99},"2022-12-12",{"date":103,"type":87},"2026-05",{"name":5,"class":6},2]